Ms. Johnson is a 49 year old administrative assistant who is currently being treated for stage 4 renal carcinoma. She has been p
rescribed an experimental treatment regimen that includes a monoclonal vascular endothelial growth factor (VEGF) inhibitor. What is the specific purpose of a VEGF inhibitor?
